Mirroring the introduction of generic drugs to compete with branded small-molecule drugs, policymakers created a path for approval of “biosimilars” to reduce prices by competing with branded biologics ...
Why do large companies sometimes lobby for regulation in their own industries? When major crypto exchanges advocate for licensing or tech companies urge regulation of artificial intelligence, the ...
OpenAI CEO Sam Altman urged lawmakers to consider regulating AI during his Senate testimony on May 16, 2023. That recommendation raises the question of what comes next for Congress. The solutions ...
September 1, 2019 may be seen as a new starting point for the enforcement of China’s antitrust and competition laws. On this date, three new sets of rules and regulations (the “Three New Regulations”) ...